Program Analysis
Graduates earn $50,276/yr, roughly in line with the $48,121 national median for Biotechnology. The value proposition here depends on cost, not earnings.
At 7.0x the cost of in-state tuition, the ten-year earnings outlook represents a strong return. Not exceptional, but meaningfully positive.
AI risk is moderate — 48% task exposure — and the 8% scenario spread suggests disruption would dent but not destroy the earnings outlook.
With first-year pay of $50,276 far exceeding the $21,500 median debt, the payback timeline is measured in months, not years.
At #12 out of 18 programs, University of New Hampshire-Main Campus's financial outcomes for Biotechnology trail the majority of peers. The value case depends on other factors.